共 50 条
- [21] The Effect of Curcumin Phytosome on the Treatment of Patients with Non-alcoholic Fatty Liver Disease: A Double-Blind, Randomized, Placebo-Controlled TrialPHARMACOLOGICAL PROPERTIES OF PLANT-DERIVED NATURAL PRODUCTS AND IMPLICATIONS FOR HUMAN HEALTH, 2021, 1308 : 25 - 35Mirhafez, Seyed RezaAzimi-Nezhad, MohsenDehabeh, MaryamHariri, MitraNaderan, Ronika DaneshMovahedi, AliAbdalla, MohammedSathyapalan, ThozhukatSahebkar, Amirhossein
- [22] Randomised Double-Blind Placebo-Controlled Trial of Inulin with Metronidazole in Non-Alcoholic Fatty Liver Disease (NAFLD)NUTRIENTS, 2020, 12 (04)Chong, Clara Yieh LinOrr, DavidPlank, Lindsay D.Vatanen, TommiO'Sullivan, Justin M.Murphy, Rinki
- [23] Quercetin supplementation in non-alcoholic fatty liver disease A randomized, double-blind, placebo-controlled clinical trialNUTRITION & FOOD SCIENCE, 2020, 50 (06): : 1279 - 1293Hosseinikia, MahboobeOubari, FarhadHosseinkia, RoghayeTabeshfar, ZibanehSalehi, Mohammad GharibMousavian, ZeinabAbbasi, MehrnazSamadi, MehnooshPasdar, Yahya
- [24] NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial (vol 391, pg 1174, 2018)LANCET, 2018, 391 (10126): : E16 - E16Harrison, S. A.Rinella, M. E.Abdelmalek, M. F.
- [25] A one-year, randomized, placebo-controlled, double-blind trial of rosiglitazone in non alcoholic steatohepatitis: Results of the FLIRT pilot trialDIABETOLOGIA, 2006, 49 : 704 - 705Ratziu, V.Jacqueminet, S.Giral, P.Podevin, P.Serfaty, L.Charlotte, F.Bruckert, E.Bernhardt, C.Grimaldi, A.Poynard, T.
- [26] Lifestyle versus ezetimibe plus lifestyle in patients with biopsy-proven non-alcoholic steatohepatitis (LISTEN): A double-blind randomised placebo-controlled trialNUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2022, 32 (05) : 1288 - 1291Noto, DavidePetta, SalvatoreGiammanco, AntoninaSpina, RossellaCabibbi, DanielaPorcasi, RossanaCaldarella, RosaliaCiaccio, MarcelloMuratore, RobertoCefalu, Angelo B.Craxi, AntonioAverna, Maurizio
- [27] A MULTICENTRIC, DOUBLE-BLIND, RANDOMISED-CONTROLLED TRIAL (RCT) OF HIGH DOSE URSODEOXYCHOLIC ACID IN PATIENTS WITH NON-ALCOHOLIC STEATOHEPATITIS (NASH)JOURNAL OF HEPATOLOGY, 2009, 50 : S21 - S21Ratziu, V.De Ledinghen, V.Oberti, F.Mathurin, P.Wartelle-Bladou, C.Renou, C.Spenard, J.
- [28] A randomized, double blind, placebo-controlled trial of htd1801 (berberine ursodeoxycholate, budc) in patients with hypercholesterolemia: implications for its use in non-alcoholic steatohepatitis (NASH)JOURNAL OF HEPATOLOGY, 2020, 73 : S440 - S441Di Bisceglie, AdrianWatts, GeraldLinberg, Bao-VanYu, LiYu, MengLavin, PhilipLiu, Liping
- [29] Vitamin D for treatment of non-alcoholic fatty liver disease detected by transient elastography: A randomized, double-blind, placebo-controlled trialDIABETES OBESITY & METABOLISM, 2020, 22 (11): : 2097 - 2106Lukenda Zanko, VesnaDomislovic, ViktorTrkulja, VladimirKrznaric-Zrnic, IrenaTurk-Wensveen, TamaraKrznaric, ZeljkoFilipec Kanizaj, TajanaRadic-Kristo, DelfaBilic-Zulle, LidijaOrlic, LidijaDinjar-Kujundzic, PetraPoropat, GoranStimac, DavorHauser, GoranMikolasevic, Ivana
- [30] Insulin sensitizer MSDC-0602K in non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled phase IIb studyJOURNAL OF HEPATOLOGY, 2020, 72 (04) : 613 - 626Harrison, Stephen A.Alkhouri, NaimDavison, Beth A.Sanyal, ArunEdwards, ChristopherColca, Jerry R.Lee, Bo HyunLoomba, RohitCusi, KennethKolterman, OrvilleCotter, GadDittrich, Howard C.